144 related articles for article (PubMed ID: 19798601)
1. [Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: results at 6 years].
Martínez Ferri M; Peña Mayor P; Pérez López-Fraile I; Castro Vilanova MD; Escartín Siquier A; Martín Moro M; Forcadas Berdusan M;
Neurologia; 2009; 24(6):360-5. PubMed ID: 19798601
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
3. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig JJ; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Aug; 85(7):580-8. PubMed ID: 26187231
[TBL] [Abstract][Full Text] [Related]
5. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
7. In utero antiepileptic drug exposure: fetal death and malformations.
Meador KJ; Baker GA; Finnell RH; Kalayjian LA; Liporace JD; Loring DW; Mawer G; Pennell PB; Smith JC; Wolff MC;
Neurology; 2006 Aug; 67(3):407-12. PubMed ID: 16894099
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
9. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.
Morrow J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; McGivern RC; Morrison PJ; Craig J
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):193-8. PubMed ID: 16157661
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
[TBL] [Abstract][Full Text] [Related]
11. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
12. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
13. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
14. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
15. Comparative Risk of Major Congenital Malformations With 8 Different Antiepileptic Drugs: A Prospective Cohort Study of the EURAP Registry.
Vossler DG
Epilepsy Curr; 2019; 19(2):83-85. PubMed ID: 30955418
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
[TBL] [Abstract][Full Text] [Related]
18. [Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: results at 6 years].
Caraballo RH
Neurologia; 2009; 24(6):359. PubMed ID: 20050109
[No Abstract] [Full Text] [Related]
19. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.
Vajda FJ; Hitchcock A; Graham J; Solinas C; O'Brien TJ; Lander CM; Eadie MJ
Eur J Neurol; 2006 Jun; 13(6):645-54. PubMed ID: 16796590
[TBL] [Abstract][Full Text] [Related]
20. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]